Chromocell to participate in life sciences investor forum september 19th

Freehold, n.j., sept. 16, 2024 (globe newswire) -- chromocell therapeutics corporation (“chromocell”, or the “company”), (nyse american: chro), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that frank knuettel, ceo, will present live at the life sciences investor forum, hosted by virtualinvestorconferences.com, on september 19th 2024.
CHRO Ratings Summary
CHRO Quant Ranking